Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease

NCT06158945 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT06158945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06158945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
October 24, 2023
Completion date
October 23, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease